The effects of poloxamer and sodium alginate mixture (Guardix-SG®) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study
Shoulder
Science
Breast Neoplasms
Pilot Projects
Poloxamer
03 medical and health sciences
0302 clinical medicine
Double-Blind Method
Humans
Prospective Studies
Hyaluronic Acid
Range of Motion, Articular
Mastectomy
Q
R
Middle Aged
Prognosis
3. Good health
Drug Combinations
Carboxymethylcellulose Sodium
Case-Control Studies
Lymphatic Metastasis
Axilla
Medicine
Lymph Node Excision
Female
Research Article
Follow-Up Studies
DOI:
10.1371/journal.pone.0238284
Publication Date:
2020-09-23T17:30:46Z
AUTHORS (19)
ABSTRACT
Purpose Restricted shoulder mobility is a major upper extremity dysfunction associated with lower quality of life and disability after breast cancer surgery. We hypothesized that poloxamer sodium alginate mixture (Guardix-SG®) applied axillary lymph node dissection (ALND) would significantly improve range motion (ROM) in patients cancer. Methods conducted double-blind, randomized, prospective study to evaluate the clinical efficacy safety Guardix-SG® for prevention ALND. The primary outcome measure was ROM at baseline (T0) 3 (T1), 6 (T2), 12 months (T3) Secondary measures were Disabilities Arm, Shoulder, Hand score(DASH), pain movement, which assessed using numeric rating scale, lymphedema body composition analyzer. Results A total 83 women randomly assigned either group or control group. In (n = 37), region 46), ALND performed without Guardix-SG®. Comparing flexion before surgery (178.2°) (172.3°), restored group, there no statistically significant difference between (p 0.182). No adverse effect observed Conclusions results this have shown help causing effects who underwent However, from further large-scale needed obtain more conclusive conclusion. Trial registration CRISKCT0003386; https://cris.nih.go.kr (20181207)
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (6)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....